| Inspire Medical Systems is a medical technology company focused on the development and commercialization of solutions for patients with obstructive sleep apnea (OSA). Co.'s proprietary Inspire system is the neurostimulation technology that provides a treatment for moderate to severe OSA. Co. has developed a solution that monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. Co. sells its Inspire system to hospitals and ambulatory surgery centers in the U.S. and in select countries in Europe through a direct sales organization, and Co. sells its Inspire system in Japan and Singapore through a distributor. The INSP average annual return since 2018 is shown above.
The Average Annual Return on the INSP average annual return since 2018 page and across the coverage universe of our site,
is a measure of the annualized return over the past ten years (or specified start date) for a given investment
(up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement
period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window
to capture long-term trends.
Thus, researching Average Annual Returns is good practice for investors — whether INSP average annual return since 2018 or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the INSP average annual return calculation with any dividends reinvested as applicable (on ex-dates).